CIK 0001689375
- Accelerated filer
- Smaller reporting company
- Emerging growth company
Entrada Therapeutics, Inc.
Sign in to watch- Ticker
- TRDA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813983399
- Phone
- +1 857-305-1825
- Business address
- ONE DESIGN CENTER PLACE, SUITE 17-500, BOSTON, MA, 02210
- Former names
- CycloPorters, Inc.
- 4 Open-market sale President and CEO sold 10,587 shares at an average $15.25 ($161,442)
- 4 Open-market sale Chief Medical Officer sold 8,593 shares at an average $15.29 ($131,428)
- 4 Open-market sale Chief Operating Officer sold 1,544 shares at an average $15.45 ($23,854)
- 4 Open-market sale President and CEO sold 4,425 shares at an average $15.10 ($66,838)
- 4 Open-market sale Chief Medical Officer sold 4,280 shares at an average $15.08 ($64,560)
- 4 Open-market sale Chief Operating Officer sold 4,293 shares at an average $15.11 ($64,878)
- 4 Open-market sale President and CEO sold 200 shares at $15.04 ($3,008)
- 4 Open-market sale Chief Operating Officer sold 100 shares at $15.01 ($1,501)
- 4 Open-market sale Chief Medical Officer sold 106 shares at $15.01 ($1,591)
- 4 Open-market sale President and CEO sold 1,788 shares at an average $15.12 ($27,039)
- 4 Open-market sale Chief Medical Officer sold 2,021 shares at an average $15.11 ($30,531)
- 4 Open-market sale Chief Operating Officer sold 1,777 shares at an average $15.11 ($26,845)
- 4 Grant or award Chief Financial Officer acquired 5,503 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 5,794 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 5,172 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 5,632 shares (grant or award)
- 4 Grant or award President and CEO acquired 15,125 shares (grant or award)
- 4 Open-market sale President and CEO sold 2,000 shares at an average $12.72 ($25,435)
- 4 Open-market sale Chief Financial Officer sold 4,669 shares at an average $13.78 ($64,362)
- 4 Open-market sale Chief Financial Officer sold 11,655 shares at an average $13.08 ($152,432)
Page 9 of 13 · 242 filings